Enovis Experiences Record-High Patent Filings and Grants in Q3 2023 August

Enovis, a leading technology company, has recently announced its remarkable achievement of experiencing record-high patent filings and grants in the...

Enovis Experiences Record-High Patent Filings and Grants in August of Q3 2023 Enovis, a leading technology company specializing in innovative...

Maintaining optimal oral health is essential for overall well-being. A healthy mouth not only allows us to eat and speak...

Understanding the eSTAR Project Management System In today’s fast-paced business environment, effective project management is crucial for the success of...

ABK Biomedical, a leading medical device company, has recently announced that its Eye90 microspheres device has received Breakthrough Device Designation...

Absci and AstraZeneca Collaborate on AI-Driven Cancer Antibody Drug Development Absci, a leading synthetic biology company, has recently announced a...

The global filter needles market is expected to witness significant growth from 2023 to 2030, according to a new report...

The global filter needles market is expected to experience significant growth from 2023 to 2030, according to a recent report...

The Role of Biotechnology Laboratory Equipment in the Growth of the Indian Bioeconomy Biotechnology has emerged as a key driver...

If you are a manufacturer of In Vitro Diagnostic (IVD) devices and looking to enter the European market, one of...

Title: An In-depth Look at Life Heater: Reviews, Effectiveness, and Potential Scam Introduction: Medical Device News Magazine aims to provide...

Title: An Urgent Customer Alert: Life Heater Reviews 2023 – Is It Truly Effective or a Scam? Insights from Medical...

Discover the Top 21 Must-Read Books of 2023 As we step into a new year, the literary world is abuzz...

The field of medical technology, or medtech, is constantly evolving with new innovations and advancements. As an entrepreneur in this...

In the ever-evolving world of healthcare, medical devices play a crucial role in improving patient outcomes and revolutionizing the way...

Potential Divestment of Grail by Illumina Amidst Impending Legal Challenges Illumina, a leading genomics company, is reportedly considering divesting its...

An Overview of the FDA’s eSTAR Program: Enhancing Safety and Transparency in Regulatory Processes The Food and Drug Administration (FDA)...

The global pain management drugs and devices market is set to experience significant growth in the coming years, driven by...

The global pain management drugs and devices market is experiencing significant growth, driven by the rising demand for minimally invasive...

Karolinska University Hospital, one of Sweden’s leading medical institutions, has recently announced a groundbreaking collaboration with two hospitals in Ukraine....

Stoke Therapeutics, a biotechnology company focused on developing treatments for severe genetic diseases, recently presented its latest findings on children...

Finding the right balance between regulation and innovation in laboratory-developed tests (LDTs) is a complex and ongoing challenge in the...

A Comprehensive Guide to Mastering ISO 10993: Medical Device Biocompatibility with Operon Strategist Introduction: In the field of medical device...

A Comprehensive Guide to Successfully Implementing ISO 10993 for Medical Device Biocompatibility: Insights from Operon Strategist Introduction: In the field...

In November, two groundbreaking devices manufactured using additive technology received innovation approvals, marking a significant milestone in the field of...

Title: A New Perspective on Women’s Health Care: Exploring Personal Wellness Introduction: In recent years, there has been a significant...

The Importance of Disposing Used Medical Equipment: 3 Key Reasons Proper disposal of used medical equipment is crucial for several...

Nevro Corporation, a leading medical device company specializing in the treatment of chronic pain, has recently announced its acquisition of...

Title: New AI Model Accurately Predicts Breast Cancer Risk, Eliminating Racial Bias Introduction Breast cancer is a significant health concern...

The Impact of AI, Automation, and Risk on MedTech In recent years, the field of medical technology, or MedTech, has...

Overview of MHRA Guidance on Registration Dependent on Expiring CE Certificates: A Comprehensive Explanation

Overview of MHRA Guidance on Registration Dependent on Expiring CE Certificates: A Comprehensive Explanation

The Medicines and Healthcare products Regulatory Agency (MHRA) is the regulatory body responsible for ensuring the safety, quality, and efficacy of medicines and medical devices in the United Kingdom. In light of the UK’s departure from the European Union, the MHRA has issued guidance on the registration process for medical devices that are dependent on expiring CE certificates. This article aims to provide a comprehensive explanation of this guidance.

Background:

Before delving into the details of the MHRA guidance, it is essential to understand the context in which it was issued. With Brexit, the UK is no longer part of the European Union’s regulatory framework for medical devices. Previously, medical devices could be placed on the UK market if they had obtained a CE certificate, which demonstrated compliance with EU regulations. However, with the end of the transition period on December 31, 2020, the UK established its own regulatory system.

MHRA Guidance:

The MHRA guidance on registration dependent on expiring CE certificates outlines the steps that medical device manufacturers need to take to continue placing their products on the UK market. It applies to devices that have a valid CE certificate issued by an EU-recognized Notified Body and are currently registered with the MHRA.

1. Grace Period:

To facilitate a smooth transition, the MHRA has introduced a grace period for medical devices with expiring CE certificates. Devices that have a valid CE certificate can continue to be placed on the UK market until June 30, 2023, without requiring a UKCA (UK Conformity Assessed) mark.

2. Registration Process:

During the grace period, manufacturers must register their devices with the MHRA. The registration process involves creating an account on the MHRA’s Device Online Registration System (DORS) and providing relevant information about the device, including its intended purpose, risk classification, and details of the manufacturer.

3. UKCA Mark:

After the grace period ends on June 30, 2023, medical devices must bear the UKCA mark to be placed on the UK market. The UKCA mark indicates that the device meets the UK’s regulatory requirements. Manufacturers will need to obtain UKCA certification from a UK-approved Conformity Assessment Body (CAB) to affix the mark.

4. Transition from CE to UKCA:

To transition from a CE certificate to a UKCA certificate, manufacturers must engage with a UK-approved CAB. The CAB will assess the device’s conformity with the UK’s regulatory requirements, which are largely aligned with the EU’s regulations. The assessment may involve a review of technical documentation, testing, and quality management system audits.

5. Impact on Supply Chain:

The MHRA guidance also addresses the impact on the supply chain. It clarifies that devices placed on the Great Britain market (England, Scotland, and Wales) must comply with the new UK regulations, while devices placed on the Northern Ireland market must continue to meet EU regulations and bear the CE mark.

Conclusion:

The MHRA guidance on registration dependent on expiring CE certificates provides a comprehensive explanation of the steps medical device manufacturers need to take to continue placing their products on the UK market. By following this guidance, manufacturers can ensure compliance with the UK’s regulatory requirements and maintain access to the UK market. It is crucial for manufacturers to familiarize themselves with this guidance and take appropriate actions within the specified timelines to avoid disruptions in their business operations.